Co-Diagnostics, Inc.
CODX
$0.34
-$0.01-2.01%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -24.86% | -5.96% | -11.62% | -22.34% | -71.09% |
| Total Other Revenue | -100.00% | -94.91% | -51.46% | -45.97% | 186.35% |
| Total Revenue | -93.06% | -89.02% | -47.63% | -42.53% | 57.16% |
| Cost of Revenue | -90.97% | -83.48% | -79.93% | -76.13% | 114.20% |
| Gross Profit | -95.21% | -92.73% | -1.78% | 11.00% | 23.37% |
| SG&A Expenses | -21.39% | -5.12% | -6.29% | -2.36% | -8.60% |
| Depreciation & Amortization | -10.26% | 0.16% | 6.59% | 11.93% | 9.61% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -23.84% | -16.89% | -15.74% | -11.15% | 2.27% |
| Operating Income | 11.17% | -0.13% | 10.79% | 6.15% | 3.88% |
| Income Before Tax | 10.84% | -0.41% | 9.07% | 1.39% | 28.54% |
| Income Tax Expenses | -129.50% | -97.83% | 109.41% | 102.07% | 139.99% |
| Earnings from Continuing Operations | 22.05% | 4.20% | 7.79% | -6.53% | 3.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 22.05% | 4.20% | 7.79% | -6.53% | 3.00% |
| EBIT | 11.17% | -0.13% | 10.79% | 6.15% | 3.88% |
| EBITDA | 11.20% | -0.13% | 11.31% | 6.68% | 4.29% |
| EPS Basic | 28.91% | 9.65% | 11.94% | -2.99% | 4.52% |
| Normalized Basic EPS | 16.53% | 3.31% | 14.24% | 8.68% | 6.32% |
| EPS Diluted | 28.26% | 9.05% | 11.59% | -2.52% | 4.87% |
| Normalized Diluted EPS | 16.53% | 3.31% | 14.24% | 8.68% | 6.32% |
| Average Basic Shares Outstanding | 11.67% | 6.51% | 4.91% | 3.35% | 2.05% |
| Average Diluted Shares Outstanding | 11.67% | 6.51% | 4.91% | 3.35% | 2.05% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |